After revising its calculations, CMS removed Gilead’s cancer cell therapies Yescarta and Tecartus, as well as 5 other medicines, from the first set of drugs subject to rebates under a provision of the IRA. […]
Cytokinetics’ candidate for the muscle disease amyotrophic lateral sclerosis, or ALS, failed a Phase III trial, the Bay Area biotech announced Friday morning. At a second interim analysis of the trial, an independent review committee recommended that C… […]
Two new research breakthroughs involving the company and its technologies make inroads into new possibilities for medicine SAN FRANCISCO, March 31, 2023 /PRNewswire/ — JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, announced … […]
A federal judge reversed a major Obamacare provision requiring plans to cover preventive care ranging from disease screenings to pregnancy care. […]
The RedSOS app decreases emergency response times with its proprietary LiveGPS technology and voice-free activation. WALNUT CREEK, Calif., March 31, 2023 /PRNewswire/ — In an emergency, every second counts, but an estimated 23 million calls to 911 are… […]
Paul Stoffels has made it clear that he views cutting jobs at Galapagos as difficult but necessary — but he’s getting creative about it. Galapagos, headquartered in Mechelen, Belgium, has struck an arrangement with French contract research organization… […]
SOUTH SAN FRANCISCO, Calif., March 31, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on March 30, 2023, the… […]
EMERYVILLE, Calif.–(BUSINESS WIRE)–OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2022, and provided operating and partner program updates. “Following the closing of the spin-off and busine… […]
FREMONT, Calif., March 30, 2023 /PRNewswire/ — Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, April 19, 2023, beginning at 2:00 p.m. Pacific Time (5:00 p.m… […]
DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2022. … […]
Copyright © 2023 Biotech Networks, LLC
